Gen-Probe Adds Influenza Tests To Diagnostics Portfolio With Prodesse Buy
This article was originally published in The Gray Sheet
Executive Summary
Nucleic acid test maker Gen-Probe will gain a growing pipeline of molecular diagnostics for infectious diseases and add flu tests for the first time through its purchase of privately-held Prodesse, announced Oct. 6